LBH589 in Refractory Myelodysplastic Syndromes (MDS)

Clinical trial NCT00594230 · TERMINATED

Trial details

NCT number: NCT00594230
Sponsor: SCRI Development Innovations, LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes (MDS)

Start date: 2008-01-01
Primary completion: 2011-03-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.